@pharmalot.bsky.social
@pharmaphorum.bsky.social#MSD has been rocked by a #courtjudgment ordering it to stop manufacturing and selling its #subcutaneous formulation of cancer immunotherapy #Keytruda in eight #Europeanmarkets.
@newsen.bsky.socialHalozyme Secures Key Legal Victory Against Merck's Keytruda in Europe #United_States #San_Diego #Halozyme #Patent #KEYTRUDA
@breastcancerorg.bsky.social#Keytruda is a type of #immunotherapy called an immune checkpoint inhibitor. It may be prescribed for some people with triple-negative breast cancer, as well as some metastatic or inoperable breast cancers with specific biomarkers, including MSI-H, dMMR, or TMB-H.
Read more: https://bit.ly/4ipejwL
